ProPhase LabsPRPH
Market Cap: $44.6M
About: ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
Employees: 113
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
0.31% less ownership
Funds ownership: 9.44% [Q1] → 9.13% (-0.31%) [Q2]
9% less funds holding
Funds holding: 32 [Q1] → 29 (-3) [Q2]
34% less capital invested
Capital invested by funds: $11M [Q1] → $7.27M (-$3.73M) [Q2]
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
93% less call options, than puts
Call options by funds: $3K | Put options by funds: $40K
Research analyst outlook
We haven’t received any recent analyst ratings for PRPH.